Ariefta, Nanang R.

Banzragchgarav, Orkhon

Batkhuu, Javzan

Battsetseg, Badgar

Battur, Banzragch

Murata, Toshihiro

Myagmarsuren, Punsantsogvoo

Nishikawa, Yoshifumi

application/pdf179 compounds in a Mongolian compound library were investigated for their inhibitory effect on the in vitro growth of Plasmodium falciparum and Toxoplasma gondii. Among these compounds, brachangobinan A at a half-maximal inhibition concentration (IC50) of 2.62 μM and a selectivity index (SI) of 27.91; 2-(2′-hydroxy-5′-O-methylphenyl)-5-(2″,5″-dihydroxyphenyl)oxazole (IC50 3.58 μM and SI 24.66); chrysosplenetin (IC50 3.78 μM and SI 15.26); 4,11-di-O-galloylbergenin (IC50 3.87 μM and SI 13.38); and 2-(2′,5′-dihydroxyphenyl)-5-(2″-hydroxyphenyl)oxazole (IC50 6.94 μM and SI 11.48) were identified as potential inhibitors of P. falciparum multiplication. Additionally, tricin (IC50 12.94 μM and SI > 23.40) was identified as a potential inhibitor of T. gondii multiplication. Our findings represent a good starting point for developing novel antimalarial and anti-Toxoplasma therapeutics from Mongolian compounds

Institutional Repositories DataBase (IRDB)

Evaluation of Mongolian compound library for potential antimalarial and anti-Toxoplasma agents

Evaluation of Mongolian compound library for potential antimalarial and anti-Toxoplasma agents

Abstract

Similar works

Full text

Available Versions

Institutional Repositories DataBase (IRDB)